ChemoCentryx Soars On Phase III Avacopan Data In ANCA Vasculitis

 
• By Mandy Jackson
  
woman in a laboratory microscope with microscope slide in hand.toned image.
ChemoCentryx and Vifor will report additional details in the coming weeks.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D